Pyridopyrimidine derivative as histamine receptor inhibitor

WO2026062171A1PCT designated stage Publication Date: 2026-03-26FAES FARMA SA

View PDF 1 Cites 0 Cited by

Patent Information

Authority / Receiving Office: WO · WO
Patent Type: Applications
Current Assignee / Owner
Filing Date: 2025-09-19
Publication Date: 2026-03-26

Application Information

Patent Timeline

19 Sep 2025

Application

26 Mar 2026

Publication

WO2026062171A1

IPC: C07D471/04; A61P1/00; A61P1/16; A61P9/00; A61P11/00; A61P11/06; A61P13/12; A61P17/00; A61P17/04; A61P19/02; A61P27/02; A61P29/00; A61P37/00; A61K31/519

CPC: C07D471/04; A61P29/00; A61P37/00; A61P17/00; A61P17/04; A61P11/00; A61P9/00; A61P13/12

Inventors: SANCHO MARTINEZ, IGNACIO; PÉREZ GÓMEZ, ANABEL

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Smart Images

Figure EP2025076772_26032026_PF_FP_ABST

Patent Text Reader

Abstract

The invention relates to the compound of formula (I) or a salt or solvate thereof, to a pharmaceutical composition comprising the same and to its use in the treatment and / or prevention of diseases or disorders mediated by histamine H4 receptor and / or by histamine H1 receptor.

Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

Pyridopyrimidines as histamine h4-receptor inhibitors
WO2020020939A1

Patent Information

Abstract

Patent Citations

Pyridopyrimidines as histamine h4-receptor inhibitors